What's breaking now, across thousands of outlets.
Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert have more information.
We haven't written up this one. CBS News has the full story — the link below goes straight to it.
The lung capacity of thousands of children stunted by traffic fumes on London’s streets recovered fully in the five years after the city imposed limits on its most polluting vehicles, a landmark study…
A hospital in east China has used reprogrammed stem cells to treat severe heart failure, with 90 per cent of patients showing significant recovery in heart function after the novel therapy.
A hospital in east China has used reprogrammed stem cells to treat severe heart failure, with 90 per cent of patients showing significant recovery in heart function after the novel therapy.
Dr. Shantanu Nundy is joining the Kentucky-based insurer from health navigation firm Accolade. He’s had a varied career — advising the FDA on AI, teaching, working for the World Bank, practicing…
The Registrar of the Medical and Dental Council, Dr Divine Ndonbi Banyubala, says the Association of Medical Councils of Africa (AMCOA) will bring together medical regulators from across the continent…
The International Coordinating Group on Vaccine Provision, which includes the WHO and other partners, said the doses will be released immediately following a request from DR Congo’s government.
